Cutaneous Squamous Cell Carcinoma Cssc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cutaneous squamous cell carcinoma (cSCC) of the head and neck region is the second most prevalent skin cancer, with metastases to regional lymph nodes occurring in 2%–5% of cases. To further our understanding of the molecular events characterizing cSCC invasion and metastasis, we conducted targeted cancer progression gene expression and pathway analysis in non-metastasizing (PRI-) and metastasizing primary (PRI+) cSCC tumors of the head and neck region, cognate lymph node metastases (MET), and matched sun-exposed skin (SES). The highest differentially expressed genes in metastatic (MET and PRI+) versus non-metastatic tumors (PRI-) and SES included PLAU, PLAUR, MMP1, MMP10, MMP13, ITGA5, VEGFA, and various inflammatory cytokine genes. Pathway enrichment analyses implicated these genes in cellular pathways and functions promoting matrix remodeling, cell survival and migration, and epithelial to mesenchymal transition, which were all significantly activated in metastatic compared to non ....

Cutaneous Squamous Cell Carcinoma Cssc , Xtracellular Matrix Ecm , Atrix Metalloproteinase Mmp , Tumor Stroma , Rokinase Plasminogen Activator Upa , Rokinase Plasminogen Activator Receptor Upar ,